• Username (E-mail)
  • Password
Dow 20,822 0.1%  EStoxx50 3,304 -0.9%  Nikkei 19,284 -0.5%  EUR 1.0562 -0.4% 
Nasdaq 5,845 0.2%  FTSE100 7,244 -0.4%  Yen 112.1440 0.0%  Oil 56.0 -0.8% 
S&P500 2,367 0.2%  DAX 11,804 -1.2%  GBP 1.2460 0.0%  Gold 1,257 0.6% 

Vertex Pharmaceuticals share [Symbol: VRTX / ISIN: US92532F1003]

04/27/2016 04:51:10 PM
04/27/2016 04:51:10 PM UTC-0400

EARNINGS SUMMARY: Details of Vertex Pharmaceuticals Inc. Q1 Earnings Report


(RTTNews) - Below are the earnings highlights for Vertex Pharmaceuticals Inc. (VRTX):

-Earnings: $22.42 million in Q1 vs. -$148.38 million in the same period last year. -EPS: $0.09 in Q1 vs. -$0.62 in the same period last year. -Analysts projected $0.29 per share -Revenue: $398.08 million in Q1 vs. $138.51 million in the same period last year.

Analyst Opinions for Vertex Pharmaceuticals Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
12/14/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
12/05/12
Vertex Pharmaceuticals RBC Capital Markets
11/13/12
Vertex Pharmaceuticals Credit Suisse Group
11/05/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
11/02/12
Vertex Pharmaceuticals UBS AG

Add or Edit Instrument

Related Stocks

Stock Market

News Ticker

News

  • News on Stocks
  • All News
pagehit